EDITORIAL

Cancer Immunotherapy

Science  20 Dec 2013:
Vol. 342, Issue 6165, pp. 1417
DOI: 10.1126/science.1249481

You are currently viewing the summary.

View Full Text

Summary

The war on cancer began a little more than 40 years ago as a national research program to radically improve the survival of patients with cancer, a leading cause of death in the United States and worldwide. The main weapons deployed have been surgery, radiation, and chemotherapy, treatments that often carry risks and/or cause adverse side effects. Although some forms of cancer yield to these therapies, not all do, and thus mortality remains high.